Skip to main content
. 2018 May 2;20:79. doi: 10.1186/s13075-018-1580-5

Fig. 2.

Fig. 2

Calibration of predicted vs observed probability of primary nonadherence in methotrexate and biologics/tofacitinib test samples. Calibration plot for (left) methotrexate (n = 179, Hosmer–Lemeshow test p = 0.014) and (right) biologics/tofacitinib (n = 111, Hosmer–Lemeshow test p = 0.484). Numbers above each line of calibration plot refer to number of patients in each decile of predicted probability in the test sample. The 45° line indicates perfect calibration